| Literature DB >> 24490152 |
Mark Lidegaard1, Rene B Jensen1, Christoffer H Andersen1, Mette K Zebis2, Juan C Colado3, Yuling Wang4, Thomas Heilskov-Hansen5, Lars L Andersen1.
Abstract
PURPOSE: This study investigates the acute and longitudinal effects of resistance training on occupational muscle activity in office workers with chronic pain.Entities:
Mesh:
Year: 2013 PMID: 24490152 PMCID: PMC3892746 DOI: 10.1155/2013/262386
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow chart.
Figure 2A schematic overview of the measurement period. Rest is equivalent to the resting period where the resting EMG amplitude was determined, REF is equivalent to the three reference tasks, and Max corresponds to the time of the maximal contraction.
Baseline characteristics, Mean ± SD. No significant differences were observed.
| Training ( | Control ( | |
|---|---|---|
| Age (years) | 41.7 ± 10.8 | 40.5 ± 7.27 |
| Height (cm) | 168.8 ± 6.68 | 166.1 ± 4.44 |
| Weight (kg) | 66.5 ± 9.07 | 65.2 ± 10.1 |
| BMI (kg | 23.3 ± 2.87 | 23.6 ± 3.58 |
| Pain intensity previous 3 weeks (Scale 0–10) | 3.44 ± 1.40 | 3.24 ± 1.37 |
| Systolic BP (mmHg) | 125 ± 12.3 | 127 ± 15.2 |
| Diastolic BP (mmHg) | 86 ± 8.37 | 84 ± 9.22 |
| Isometric muscle strength (Nm) | 41.1 ± 6.71 | 37.6 ± 13.21 |
| Computer use (% work time) | 98.4 ± 6.25 | 95.0 ± 10.4 |
| Weekly working time (hours) | 38.2 ± 3.9 | 37.0 ± 3.47 |
| Duration of office work (Years) | 10.3 ± 8.6 | 11.7 ± 8.9 |
Recording time corresponding to the average number of total minutes recorded. Effective recording time corresponding to the percentage time where the participants were present in the predefined data collection area, that is, percentage of the total minutes recorded included in the data analysis, median (interquartile range). No significant differences were observed.
| Training ( | Control ( | ||
|---|---|---|---|
| Recording time (min) | |||
| Before daily training session | Week 0 | 60.0 (42.0–69.1) | 64.5 (49.8–79.2) |
| Week 10 | 72.1 (65.3–77.4) | 75.5 (56.8–87.8) | |
| After daily training session | Week 0 | 82.7 (70.1–96.2) | 60.9 (47.9–74.4) |
| Week 10 | 62.3 (39.6–82.6) | 59.7 (46.7–73.2) | |
| Effective recording time (%) | |||
| Before daily training session | Week 0 | 79.7 (70.8–92.9) | 84.2 (71.9–95.1) |
| Week 10 | 89.3 (84.3–92.5) | 93.6 (40.9–97.3) | |
| After daily training session | Week 0 | 92.2 (73.4–97.0) | 93.3 (87.9–95.1) |
| Week 10 | 93.7 (85.6– 98.5) | 94.3 (73.5–97.1) |
Frequency of EMG gaps (periods per minute below 0.5% EMGmax) for m. trapezius and m. splenius, median (interquartile range).
| Training ( | Control ( | ||
|---|---|---|---|
| Trapezius | |||
| Before daily training session | Week 0 | 8.5 (4.4–11.6) | 4.2 (1.9–11.5) |
| Week 10 | 8.2 (6.3–15.3) | 3.7 (1.1–13.2) | |
| After daily training session | Week 0 | 7.4 (5.4–11.7) | 3.0 (2.0–12.2) |
| Week 10 | 7.6 (4.4–15.2) | 2.2 (1.2–6.4) | |
| Splenius | |||
| Before daily training session | Week 0 | 3.1 (1.4–10.9) | 5.0 (1.6–10.9) |
| Week 10 | 12.3 (4.8–15.2)b | 1.1 (0.5–5.8) | |
| After daily training session | Week 0 | 5.0 (2.7–7.8) | 3.1 (1.3–11.7) |
| Week 10 | 8.0 (3.5–14.5)d | 1.3 (0.5–6.5) |
b P < 0.05 significant change from baseline to follow-up in the training group compared with the control group. d P < 0.05 significant change from before to after the daily training session.
Pain intensity and muscular strength at week 0 and week 10, Mean ± SD.
| Training ( | Control ( | ||
|---|---|---|---|
| Pain intensity (scale 0–10) | Week 0 | 3.44 ± 1.40 | 3.24 ± 1.37 |
| Week 10 | 2.04 ± 1.60a | 3.45 ± 1.99 | |
| Isometric muscle strength (Nm) | Week 0 | 41.1 ± 1.7 | 37.6 ± 3.4 |
| Week 10 | 43.2 ± 1.3b | 36.5 ± 3.3 |
a P < 0.01 significant change from baseline to follow-up in the training group compared with the control group. b P < 0.05 significant change from baseline to follow-up in the training group compared with the control group.
Duration of each EMG gap (seconds) under 0.5% EMGmax for m. trapezius and m. splenius, median (interquartile range).
| Training ( | Control ( | ||
|---|---|---|---|
| Trapezius | |||
| Before daily training session | Week 0 | 0.72 (0.6–1.74) | 0.9 (0.54–1.68) |
| Week 10 | 1.26 (0.6–1.98)b | 0.6 (0.42–1.02) | |
| After daily training session | Week 0 | 1.08 (0.66–1.8) | 0.96 (0.6–1.38) |
| Week 10 | 1.56 (0.72–2.76) | 0.78 (0.36–1.26) | |
| Splenius | |||
| Before daily training session | Week 0 | 0.42 (0.36–0.48) | 0.6 (0.48–0.96) |
| Week 10 | 0.72 (0.54–0.78)a | 0.36 (0.3–0.48) | |
| After daily training session | Week 0 | 0.54 (0.42–0.6) | 0.54 (0.42–0.72) |
| Week 10 | 0.72 (0.54–1.02) | 0.48 (0.42–0.54) |
a P < 0.01 significant change from baseline to follow-up in the training group compared with the control group. b P < 0.05 significant change from baseline to follow-up in the training group compared with the control group.
(a)
| Training ( | Control ( | |||
|---|---|---|---|---|
| Trapezius | 0.5% EMGmax | |||
| Before daily training session | Week 0 | 18.5% (5.1–39.1) | 11.4% (4.3–17.6) | |
| Week 10 | 24.0% (16.0–34.6) | 4.1% (0.9–27.8) | ||
| After daily training session | Week 0 | 15.1% (11.1–30.2) | 9.8% (3.1–12.7) | |
| Week 10 | 25.8% (13.4–42.2) | 4.9% (1.5–7.9) | ||
| 1.0% EMGmax | ||||
| Before daily training session | Week 0 | 39.0% (14.1–50.8) | 21.3% (7.6–34.1) | |
| Week 10 | 32.3% (24.3–54.8) | 9.9% (2.9–35.5) | ||
| After daily training session | Week 0 | 25.9% (21.2–41.2) | 12.6% (6.3–26.0) | |
| Week 10 | 37.0% (20.7–54.3) | 6.6% (3.9–13.9) | ||
| 1.5% EMGmax | ||||
| Before daily training session | Week 0 | 47.3% (24.3–57.3) | 28.3% (10.2–43.9) | |
| Week 10 | 38.6% (32.3–66.1) | 19.5% (5.1–40.4) | ||
| After daily training session | Week 0 | 36.1% (29.1–50.6) | 15.2% (10.5–33.3) | |
| Week 10 | 46.2% (26.5–62.8) | 11.0% (5.7–18.8) | ||
| 2.0% EMGmax | ||||
| Before daily training session | Week 0 | 55.0% (37.6–61.9) | 34.7% (15.6–52.3) | |
| Week 10 | 44.5% (39.2–72.9) | 27.9% (7.3–47.7) | ||
| After daily training session | Week 0 | 44.9% (35.8–58.3) | 19.5% (14.2–39.4) | |
| Week 10 | 53.6% (32.9–74.7) | 14.4% (7.8–28.5) |
(b)
| Training ( | Control ( | |||
|---|---|---|---|---|
| Splenius | 0.5% EMGmax | |||
| Before daily training session | Week 0 | 2.3% (1.0–20.7) | 7.1% (3.8–11.1) | |
| Week 10 | 15.6% (11.7–28.5)a | 0.8% (0.2–4.6) | ||
| After daily training session | Week 0 | 5.0% (2.2–8.9) | 4.1% (1.3–10.4) | |
| Week 10 | 14.3% (8.5–20.0) | 1.9% (0.3–5.9) | ||
| 1.0% EMGmax | ||||
| Before daily training session | Week 0 | 7.6% (5.8–35.1) | 11.1% (6.4–24.7) | |
| Week 10 | 26.0% (21.9–45.0)b | 3.5% (1.4–12.6) | ||
| After daily training session | Week 0 | 11.9% (4.3–19.4) | 5.9% (2.0–22.5) | |
| Week 10 | 23.9% (12.3–29.8) | 3.7% (1.0–12.4) | ||
| 1.5% EMGmax | ||||
| Before daily training session | Week 0 | 18.2% (11.1–48.5) | 21.0% (7.6–29.8) | |
| Week 10 | 37.2% (29.8–55.4) | 7.3% (2.8–20.8) | ||
| After daily training session | Week 0 | 24.6% (10.1–37.6) | 8.2% (4.6–32.5) | |
| Week 10 | 34.2% (19.2–40.8) | 5.7% (2.5–18.8) | ||
| 2.0% EMGmax | ||||
| Before daily training session | Week 0 | 30.1% (19.8–57.9) | 31.0% (10.7–37.8) | |
| Week 10 | 46.0% (36.2–62.6) | 10.6% (5.4–29.3) | ||
| After daily training session | Week 0 | 35.1% (19.9–51.2) | 11.9% (8.8–35.5) | |
| Week 10 | 41.0% (29.8–52.8) | 9.7% (4.3–26.5) |
a P < 0.01 significant change from baseline to follow-up in the training group compared with the control group. b P < 0.05 significant change from baseline to follow-up in the training group compared with the control group.